posttransplant tacrolimus-induced diabetic ketoacidosis: review of the literature
;Zaid Ammari;Stella C. Pak;Mohammed Ruzieh;Osama Dasa;Abhinav Tiwari;Juan C. Jaume;Maria A. Alfonso-Jaume
chemosensors2018Vol. 2018pp. -
217
ammari2018caseposttransplant
Abstract
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.